Literature DB >> 1320323

Relationships between Lewy bodies and pale bodies in Parkinson's disease.

G E Dale1, A Probst, P Luthert, J Martin, B H Anderton, P N Leigh.   

Abstract

The prevalence of pale bodies and Lewy bodies was studied in the substantia nigra of 12 patients with typical Parkinson's disease (PD), in 5 patients with diffuse Lewy body disease (DLBD), and in a group of neurologically normal controls. Anti-ubiquitin antibodies labelled pale bodies and Lewy bodies in typical PD and DLBD, and there was a strong positive correlation between numbers of ubiquitin-immunoreactive pale bodies and Lewy bodies. BF10, a monoclonal antibody against a phosphate-dependent epitope of neurofilament 155-kDa polypeptide subunit, immunolabelled 57% of Lewy bodies and 15% of pale bodies in typical PD. Some pale bodies and Lewy bodies were seen in the substantia nigra of 2 of 5 neurologically normal, aged controls, probably representing "incidental PD". We conclude that there is a close relationship between pale bodies and typical Lewy bodies in the substantia nigra in clinical varieties of PD, and that these inclusions share antigenic determinants. If pale bodies and Lewy bodies reflect separate aspects of the cellular pathology in PD, their formation probably occurs in parallel. Alternatively, these observations may suggest that pale bodies represent a stage in the formation of Lewy bodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320323     DOI: 10.1007/bf00310030

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  The brain-stem lesions in Parkinsonism.

Authors:  J G GREENFIELD; F D BOSANQUET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Ubiquitin-protein conjugates in Alzheimer's lesions.

Authors:  G M Cole; P S Timiras
Journal:  Neurosci Lett       Date:  1987-08-18       Impact factor: 3.046

4.  Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

Authors:  S Kuzuhara; H Mori; N Izumiyama; M Yoshimura; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Alzheimer dementia and Pick's disease: neurofibrillary tangles and Pick bodies are associated with identical phosphorylated neurofilament epitopes.

Authors:  J Ulrich; M Haugh; B H Anderton; A Probst; C Lautenschlager; B His
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  Lewy bodies of Parkinson's disease contain neurofilament antigens.

Authors:  J E Goldman; S H Yen; F C Chiu; N S Peress
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.

Authors:  S Love; T Saitoh; S Quijada; G M Cole; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1988-07       Impact factor: 3.685

9.  Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.

Authors:  J Lowe; A Blanchard; K Morrell; G Lennox; L Reynolds; M Billett; M Landon; R J Mayer
Journal:  J Pathol       Date:  1988-05       Impact factor: 7.996

10.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

View more
  25 in total

1.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

3.  Spinal cord involvement in Lewy body-related α-synucleinopathies.

Authors:  Raffaele Nardone; Yvonne Höller; Francesco Brigo; Viviana Versace; Luca Sebastianelli; Cristina Florea; Kerstin Schwenker; Stefan Golaszewski; Leopold Saltuari; Eugen Trinka
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

4.  Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.

Authors:  Kateri J Spinelli; Jonathan K Taylor; Valerie R Osterberg; Madeline J Churchill; Eden Pollock; Cynthia Moore; Charles K Meshul; Vivek K Unni
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

Review 5.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

6.  An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.

Authors:  K Hayashida; S Oyanagi; Y Mizutani; M Yokochi
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Diffuse Lewy body disease as substrate of primary lateral sclerosis.

Authors:  J A Hainfellner; P Pilz; H Lassmann; G Ladurner; H Budka
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

8.  Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector.

Authors:  Anke Van der Perren; Cindy Casteels; Koen Van Laere; Rik Gijsbers; Chris Van den Haute; Veerle Baekelandt
Journal:  J Vis Exp       Date:  2016-02-28       Impact factor: 1.355

Review 9.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 10.  Formation and development of Lewy pathology: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.